Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India.
about
A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus.Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.Canagliflozin: A Review in Type 2 Diabetes.Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal.
P2860
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and safety of canagli ...... diabetes mellitus from India.
@en
type
label
Efficacy and safety of canagli ...... diabetes mellitus from India.
@en
prefLabel
Efficacy and safety of canagli ...... diabetes mellitus from India.
@en
P2093
P2860
P356
P1476
Efficacy and safety of canagli ...... diabetes mellitus from India.
@en
P2093
Bipin Sethi
Ganapathi Bantwal
Gary Meininger
K M Prasanna Kumar
Pramod Gandhi
P2860
P304
P356
10.4103/2230-8210.179996
P577
2016-05-01T00:00:00Z